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LEGAL STEPS LEADING TO THE BAN
The EPA’s Asbestos Ban and Phase–out Rule (1) 
was enacted in 1989, prohibiting all use of asbestos in 
the US. In 1991, the US Court of Appeals for the Fifth 
Circuit revoked the ruling (2). The main justification of 
the withdrawal was that EPA had not analysed other 
“less burdensome” options to achieve the acceptable 
level of risk, did not produce sufficient proof for the 
justification of the ban, and therefore did not prove 
to have chosen “the least burdensome reasonable 
option”, as requested by the US Toxic Substances 
Control Act. EPA had not evaluated the potential risks 
associated with substitute materials, some of which 
are carcinogenic. The Court particularly criticized the 
EPA’s decision to prohibit the production and the use 
of asbestos–cement pipes for water supply, as it had 
not assessed the possible risks of polyvinyl chloride 
and ductile iron that would be used as substitutes 
which, even according to EPA, may cause cancer 
mortality. The Court also criticized EPA for not 
having assessed the risk of the use of automobile 
brakes without asbestos; the Court concluded that 
there was convincing evidence that brakes without 
asbestos could significantly increase the number of 
traffic fatalities. The Court also expressed its opinion 
that the decision to ban the use of asbestos paper 
and some other roofing materials on the ground of 
causing one statistical death in a period of 13 years 
is a nonsense if this risk is compared, e.g., with the 
fact that every year, one person in the US dies from 
swallowing a toothpick. The Court also deemed 
unacceptable the EPA’s readiness to spend 23.7 million 
dollars for saving less than 1/3 of a statistical life in 
13 years, the price that has never been accepted to 
support a safety regulation. In 1991, the Commission 
of European Communities issued the Directive 659 
prohibiting the marketing and use of all amphibole 
fibres and of products containing amphibole fibres (3). 
It also prohibited the use of 14 categories of chrysotile 
products, permitting, however, the continuation of 
the use of the most important chrysotile products 
– asbestos cement, friction materials and insulating 
or sound proofing materials of greater density than 
1 g/cm3 (Table 1).
In 1999, the European Commission extended the 
1991 Directive 659 to the marketing and the use of 
the remaining chrysotile (4), thus banning the use 
of all the types of asbestos in member–states by the 
year 2005. The amended Annex to the Directive is 
in Table 2. 
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Table 1 Annex to Directive 76/769/EEC as amended by the Commission of the European Communities in 1991, prohibiting the placing on the 











6.1. The placing on the market and use of these fibres and of products 
containing these fibres intentionally added shall be prohibited.
6.2. Chrysotile, 
CAS No 12001–29–5
6.2. The placing on the market and use of products containing this 
fibre shall be prohibited for:
(a) toys;
(b) materials or preparations intended to be applied by 
spraying;
(c) finished products which are retailed to the public in powder 
form;
(d) items for smoking such as tobacco pipes and cigarette and 
cigar holders;
(e) catalytic filters and insulation devices for incorporation in 
catalytic heaters using liquefied gas;
(f) paints and varnishes;
(g) filters for liquids. 
By way of derogation, this prohibition will not apply to filters 
for medicinal use until after 31 December 1994;
(h) road surfacing material where the fibre content is greater 
than 2%;
(i) mortars, protective coatings, fillers, sealants, jointing 
compounds, mastics, glues, decorative powders and 
finishes;
(j) low density insulating or soundproofing materials (density 
less than 1 g/cm3);
(k) air filters and filters in transport distribution and utilization of 
natural gas and town gas;
(l) underlays for plastic floor and wall coverings;
(m) textiles finished in the form intended to be supplied to the 
end use unless treated to avoid fibre release. 
By way of derogation, this prohibition will not apply 
to diaphragms for electrolysis processes until after 31 
December1998;
(n) roofing felt.
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POSITION OF THE SCIENTIFIC COMMITTEE 
ON TOXICITY, ECOTOXICITY AND THE 
ENVIRONMENT ON HUMAN HEALTH RISKS 
FROM CHRYSOTILE (FEBRUARY 1998)
The Directorate General III (Industry) of 
the European Commission commissioned the 
Environmental Resources Management (ERM) of 
Oxford, England to make an analysis of the latest 
evidence that a change in the risk assessment for 
chrysotile is necessary. The Scientific Committee on 
Toxicity, Ecotoxicity and the Environment (SCTEE) 
of the Commission was requested to assess this 
analysis. The assessment of SCTEE was intended 
to be the basis for the Commission’s decision as to 
whether a change of the Directive 659 of 1991 was 
necessary. The following are the main points of the 
SCTEE report (5):
"–  The ERM report provides no new evidence which 
indicates that a change in the risk assessment for 
chrysotile is appropriate.
–  There is a substantial body of information on 
chrysotile albeit at high exposure levels. Neither 
epidemiology nor the animal data is sufficient 
to identify the nature of the dose–response 
relationship at the low doses which reflect current 
exposure in Europe. Consequently, it is not 
possible to be certain whether or not there is a 
true threshold dose for lung carcinogenesis or 
mesothelioma.
–  The ERM statement that the main fibrous 
alternatives to chrysotile asbestos are 
polyvinylalcohol, cellulose and para–aramid fibres 
is not complemented by adequate information on 
the technical performance of these materials which 
render them main alternatives. ERM acknowledges 
that little research has been carried out on hazards 
and risks posed by candidate substitutes to 
chrysotile. Nevertheless, it is concluded that each 
of these types of fibre is likely to pose less of a risk 
than chrysotile. In fact, …the report provides no 
criteria for comparing hazards and risks (at the 
same level of technical performance) of chrysotile, 
MMMFs and other substitute fibres.
–  For the substitute materials, with the exception of 
vitreous fibres, there is no significant epidemiology 
base to judge the human health risks. The 
conclusion that specific substitute materials 
pose a substantially lower risk to human health, 
particularly public health, than the current use of 
chrysotile, is not well founded.











6.1. The placing on the market and use of these fibres and of products 
containing these fibres added intentionally shall be prohibited.
6.2. Chrysotile, 
CAS No 12001–29–5
6.2. The placing on the market and use of this fibre and of products 
containing this fibre added intentionally shall be prohibited.
However, Member States may except diaphragms for existing 
electrolysis installations until they reach the end of their service 
life, or until suitable asbestos–free substitutes become available, 
whichever is the sooner. The Commission will review this 
derogation before 1 January 2008.
206
– The SCTEE recommends a proper evaluation of 
public, occupational and para–occupational health 
risks posed by the candidate substitutes.
–  Major concerns on the general quality of the ERM 
analysis include the following: 1. It is based on 
materials submitted by member–states. This has 
led to a preponderance of nonscientific material 
and submissions by interest groups in the list of 
references. 2. No active and systematic effort has 
been made in order to trace the available scientific 
literature. 3. It is based on reviews prepared by 
others. 4. In many points it is unclear whether 
remarks referred to any type of asbestos or 
specifically to chrysotile." 
Clearly, the SCTEE assessment of the ERM’s 
analysis is negative, generally concluding that data 
on health effects of candidate substitutes are scarce, 
that there are insufficient data to evaluate the dose–
response relationship at the current low exposures 
of chrysotile, and that there is no scientific basis 
for the conclusion that specific substitute materials 
pose a significantly lower risk to human health than 
chrysotile.
OPINION ON CHRYSOTILE ASBESTOS AND 
CANDIDATE SUBSTITUTES (SEPTEMBER 
1998)
In September 1998, only eight months after the 
first assessment, the SCTEE issued a new, completely 
different assessment of the same ERM analysis (6). 
Follow the main points of the second assessment 
which summarise their change of opinion: 
"– Chrysotile is a proven carcinogen and there is not 
sufficient evidence that it acts through nongeno-
toxic mechanism. Thus a cautionary approach is 
that there is no threshold for the carcinogenic 
effect of this agent. Regarding the candidate sub-
stitutes (i.e., cellulose, PVA, p–aramid fibres), there 
is neither evidence of carcinogenicity nor reliable 
toxicological information for identifying no effect 
levels, if any.
–  No epidemiological studies or observations in 
humans of long term effects of p–aramide or 
PVA have been reported… in scientific literature 
probably …because of the limited number of 
person–year–observations. 
–  A recent review summarizes published studies on 
4 cohorts of workers exposed to cellulose fibres. 
Excesses of cancer death were reported in some 
of the studies. 
–  To the knowledge of the SCTEE no cases of 
lung fibrosis have been reported among workers 
exposed to either …p–aramid, cellulose or PVA 
fibres. In fact, the medium and long term effects 
of each of these three agents on the lung function 
have been investigated to a limited extent.
–  Dermatoses may occur in workers exposed to 
p–aramid, at an unknown frequency.
–  As for cellulose fibres, a study on workers in a 
soft paper mill production unit exhibited excess 
mortality from chronic obstructive pulmonary 
disease and asthma, with no excess of cancer 
deaths. Workers in this unit also exhibited a 
decrease in lung vital capacity and residual 
pulmonary volume.
–  In rats, chrysotile produced mesotheliomas 
and lung carcinomas after inhalation and 
mesotheliomas after intrapleural administration. 
For most of these experiments, it is not known 
whether and to which extent the chrysotile, which 
was administered to animals, was contaminated 
with amphiboles. 
–  No adequate long term carcinogenicity experiment 
with either cellulose or PVA fibres has been reported 
in the published literature.
–  The toxicity of cellulose fibres has recently been 
reviewed. These fibres were found to be toxic to 
mouse macrophages in vitro, as shown by the 
release of lactic dehydrogenase. Cellulose fibres 
have been shown to be as effective as chrysotile in 
stimulating macrophages to release inflammogenic 
substances, such as interleukin–1, and were more 
effective than asbestos in stimulating the release 
of prostaglandins. Cellulose powder instilled into 
rat lung produced a persistent granulomatous 
response.
–  Very little information is available on the pulmonary 
toxicity of PVA fibres in laboratory animals.
–  P–aramid was inactive in gene mutation tests 
in bacteria in mammalian cells. No adequate 
evaluation of genotoxicity can be done. No data 
have been found for polyvinylalcohol and for 
cellulose fibres.
–  Conclusions: No evidence of fibre–caused cancer 
occurrence in men is available for any of the three 
candidate substitutes. Admittedly, for cellulose 
fibres, this may reflect limitations in the design 
of the underlying studies, whereas the lack of 
epidemiological studies on PVA and p–aramid may 
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be due to the relatively short time elapsed since the 
onset of industrial uses of these materials. 
–  Acute and subacute toxicity data on the three 
substitute fibres are very meagre and do not 
allow for a proper comparison with chrysotile, 
with the possible exception of p–aramid, which 
in experiments in rats was shown to cause less 
inflammation and cellular proliferation than 
chrysotile given at similar doses. In vitro, the ability 
of cellulose to induce certain inflammation–related 
changes seems greater than that of chrysotile”.
After reporting the serious lack of toxicological data 
for all three candidate substitute fibres, the SCTEE 
concluded:
“Both for the induction of lung and pleural 
cancer and lung fibrosis and for other effects, it 
is unlikely that either cellulose, PVA, or p–aramid 
fibres pose an equal or greater risk than chrysotile 
asbestos”.
As can be assessed from the parts of their report 
preceding their conclusions and even from parts of 
the Conclusions, the SCTEE final evaluation is not 
supported by sufficient scientific evidence.
The last sentence of the SCTEE report makes it 
clear that the Committe also felt that way: “SCTEE 
also strongly recommends expansion of research 
in the areas of toxicology and epidemiology of the 
substitute fibres”. It is a strange recommendation 
after having recommended the substitution of these 
fibres for chrysotile asbestos. It is out of line with the 
ILO recommendation in the Convention Concerning 
Safety in the Use of Asbestos (7) “The replacement of 
asbestos or of certain types of asbestos or products 
containing asbestos by other materials or products 
or the use of the alternative technology, should be 
scientifically evaluated by a competent authority as 
harmless or less harmful”.
SCIENTIFIC JUSTIFICATION FOR THE NEW 
DIRECTIVE
The EU scientific justification for the amendment 
to the Directive 659 on the basis of the ERM and the 
SCTEE reports is summarised below (8):
“–  No threshold level of exposure has been identified 
below which chrysotile does not pose carcinogenic 
risks and (on the basis of available information) 
substitutes are available for the majority of current 
uses of chrysotile and they are likely to pose less 
of a risk to health than chrysotile.
–  It may be appropriate, in the absence of definitive 
information, to assume that there is no safe dose 
of chrysotile. 
–  The conclusion that specific substitute materials 
pose a substantially lower risk to human health, 
particularly public health, than the current use of 
chrysotile, might eventually prove to be correct.
–  More data should be gathered on the risks of 
the main substitutes so that they could better 
compare the risks with chrysotile. 
–  The expansion of research in the areas of toxicology 
and epidemiology of substitute fibres as well as in 
the technology of the development of new, thicker 
(less respirable) fibres is recommended.”
The wording obviously reflects the hesitancy and 
the uncertainty of the SCTEE with respect to their own 
conclusions. The phrases, such as “in the absence of 
definitive information”, “might eventually prove to be 
correct”, “more data needed for better comparing the 
risks”, and “on the basis of available information”, are 
indicative of their own doubts.
CALL FOR AN INTERNATIONAL BAN AND THE 
COMMENT ON THE CALL
The Collegium Ramazzini called for an immediate 
ban on all asbestos mining and use, “which must 
be international in scope and must be enforced in 
every country of the world” (9, 10). According to 
the Collegium: “1. asbestos is an occupational and 
environmental hazard of catastrophic proportions for 
which safer substitutes exist, 2. ‘controlled use’ is not 
possible, 3. early indication that chrysotile might be 
less dangerous than other forms of asbestos have 
not been supported, and 4. the strictest occupational 
exposure limits in the world for chrysotile asbestos 
(OSHA: 0.1 f/ml of air) are estimated to be associated 
with life–time risks of 5 per 1,000 for lung cancer and 
2 per 1,000 for asbestosis”.
A number of papers do not support the approach 
of the Collegium Ramazzini (11–15).
With reference to points 1 and 2, the Collegium 
provides no data to support the statement that 
safer substitutes exist and that the ‘controlled use’ 
of asbestos is not possible. As for the 3rd point, by 
saying that early indications that chrysotile might be 
less dangerous have not been supported [giving as 
reference the IPCS Environmental Health Criteria 203 
(16)], the Collegium distorts the content of the Criteria. 
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In fact, there is a statement in the Evaluation of the 
Criteria Document that endorses the evaluation of the 
previous IPCS Criteria Document 53 from 1986 which 
addressed all types of asbestos, including chrysotile 
(17): “The risk of mesothelioma in chrysotile–exposed 
workers is less than that in workers exposed to 
crocidolite or amosite”. As for the 4th point, the 
reference to the strictest occupational exposure limit 
in the world for chrysotile is wrong, as the exposure 
limit (OSHA) concerns all types of asbestos and not 
chrysotile alone. Besides, the OSHA exposure limit 
is based on the data obtained from the production 
and use of asbestos insulation, which mainly involve 
amphiboles whose unit risk, even according to EPA 
[Table 3 in (21)], is considerably higher than that of 
chrysotile (KL amosite 430, KL chrysotile 2.3 or 9.8).
The Collegium’s choice of supportive literature 
clearly shows that it deliberately overestimates the 
risks of chrysotile, disregarding the majority of 
published asbestos risk assessments (including those 
with subjects exposed mainly to chrysotile asbestos). It 
mainly relies on the papers by Selikoff and co–workers 
(18–20) investigating the consequences of exposure 
to obviously more hazardous amphiboles (21) and 
on one cohort study of textile workers (22) with an 
extraordinarily high slope of exposure–response 
relationship which is 10–30 times higher than in 
chrysotile miners (21). Obviously, the Collegium 
intentionally omitted the largest cohort study ever 
of Canadian chrysotile miners by McDonald and 
co–workers. It is unacceptable that not a single 
reference to McDonald and co–workers has been 
made, although this group has published the greatest 
number of papers on chrysotile asbestos exposure in 
the world literature (see references 47–53 in 21). It is 
clear that the mining industry must be a useful source 
of information for asbestos risk assessment because 
it produces fibres for all the other asbestos industries. 
It has been shown (15, 23) that risks of asbestosis, 
lung cancer and mesothelioma are 15–50 times lower 
in chrysotile than in amphibole miners. The same 
has also been shown for nonoccupational exposure 
(12, 24). It is clear that risk assessment of chrysotile 
exposure must be based on subjects exposed to this 
type of asbestos and not predominantly to amphiboles. 
Even the KL data of EPA [presented in Table 3 of the 
first part of this paper (21)] clearly show the difference 
in unit risks between chrysotile and amphiboles.
Referring to the paper by Camus and co–workers 
(12), the Collegium emphasised that a recent study 
of women residing in communities in Canadian 
asbestos mining areas showed a sevenfold increase 
in death rate from pleural cancers, but intentionally 
ignored the finding reported in the same paper that no 
excess of lung cancers among residents of the same 
mining towns was found, and that even the quoted 
number of mesotheliomas is at least 20 times lower 
than that which would be calculated using the EPA 
model (11).
The two most comprehensive asbestos risk reviews 
issued by the US Health Effects Institute (HEI) and 
Institut National de la Santé et de la Recherche 
Médicale (INSERM) (25, 26) showed that excess 
lung cancers, pleural mesotheliomas, and peritoneal 
mesotheliomas in mainly amphibole industries are 3, 
12, and 30 times more frequent, respectively than in 
chrysotile industries for an equal number of expected 
cases.
Rickards (27) reported that the current controlled 
occupational exposure is practically 1,000 times lower 
than in the past. In other words, workers who are now 
exposed to chrysotile run at least 1,000 times lower 
lifetime risk than those who were exposed to the 
mixture of asbestos fibres in the past. This translates 
into 1–5 per 100,000, or the estimation 20–100 times 
lower than that of the Collegium Ramazzini (14).
Camus is very reserved about the Collegium’s 
argument that there are safer substitutes (14) and 
refers to opposing evidence in papers showing that 
PVA and p–aramid (kevlar fibres), and cellulose are 
more biopersistent than chrysotile, that p–aramid 
fibres induced fibrosis and mesothelioma in animal 
studies, and that cellulose produced cytotoxic 
effects.
CONCLUSIONS
The asbestos dilemma continues. Or rather, the 
chrysotile dilemma, as the amphiboles are no longer 
an issue, except for the tremolite asbestos as an 
impurity in chrysotile.
Although the dose–response relationship has 
been clearly established for diseases associated with 
the pure chrysotile such as fibrosis, lung cancer, and 
mesothelioma, there is a disagreement regarding 
the dose–response curve at low doses. Some 
authors believe that the dose–response relationship 
for chrysotile is a threshold phenomenon while 
others strongly oppose this proposition. The issue 
becomes even more complex, as the unit risks 
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(expressed as the increase in lung cancer risk per unit 
of cumulative exposure) vary widely among different 
types of exposure (16): by far the greatest cancer risk is 
associated with the textiles (0.01–0.03), considerably 
lower are the risks associated with the production of 
asbestos cement (0.0003–0.007), the manufacture 
of friction materials (0.0005–0.0006), and chrysotile 
mining (0.0006–0.0017). The relative risks of lung 
cancer in relation to cumulative exposure in chrysotile 
textile workers were shown to be 20–30 times 
steeper than those in chrysotile mining, production 
of friction materials or in chrysotile cement product 
manufacture. In asbestos cement production, the 
standard mortality rates from lung cancer in groups 
exposed almost exclusively to chrysotile were not 
found to be significantly increased; in the manufacture 
of friction materials for brakes and clutches there was 
practically no relationship between the relative risk and 
exposure. In chrysotile miners and millers, the increase 
in the relative risk was found only in heavy cumulative 
exposure or in exposure to chrysotile contaminated 
with tremolite. Relevant studies claim that there is 
a practical threshold of exposure below which no 
measurable health effect should be expected (21).
This does not mean that chrysotile does not pose 
a risk to human health. Exposure to chrysotile has 
caused cancers, but the current cancers are the 
consequence of high exposure of 30–50 years ago. 
Whether chrysotile will cause these events in future, 
and to what extent, depends on the current types and 
levels of exposure which are incomparably lower.
Unfortunately, there is a general mistrust between 
those who support the ‘amphibole hypothesis’ and 
those who oppose it. Scientists are divided in two 
practically irreconcilable groups. Suspicions have 
been expressed that some scientific findings have 
been conditioned by financial support from asbestos 
producing industries or countries, while others have 
raised the question whether findings supporting the 
total ban of all types of asbestos are free from the 
influence of those industries or countries that produce 
and export non–asbestos substitute materials.
The call for an eventual ban of all types of 
asbestos is at least partly motivated by the just 
interest for protecting human health from a recognized 
carcinogen. However, the insistence to immediately 
replace it by substitutes of unknown toxicity and, 
particularly, of unknown risk to human health, raises 
suspicion of hidden motives. The EU decision to ban 
asbestos, in spite of the lack of scientific support by 
their own Scientific Committee, must have been 
politically motivated. Eventually, it might prove to be 
a good decision, but there is no defendable basis 
for it until the potential substitutes are objectively 
evaluated. At the moment, Europe faces a situation 
similar to that of the US EPA in 1991 when the Court 
of Appeals for the Fifth District revoked their Ban and 
Phase–out Rule.
As for Croatia, let me summarise what I recently 
wrote in a paper entitled “The Time to Get Ready 
for the Problems Caused by Airborne Fibres?” (28). 
In view of Croatia’s intention to join the European 
Union, there is no doubt it will have to adopt the EU 
legislation, including, of course, the asbestos ban. This 
raises the following questions: 1. Should the country 
pass a phase–out rule on asbestos to be applied by 
the year 2005 (EU enforcement deadline), although 
it will not become the member of EU by that time? 
2. Should it already give more consideration to the 
possible risks related to the use of other airborne fibres 
and should the corresponding exposure thresholds be 
introduced for such fibres? 3. Should definitions of 
regulated health–related airborne fibres be adopted 
and the method for their sampling and concentration 
determination standardized? 4. Should the exposure 
thresholds also be passed for carcinogenic fibres, and 
if so, should there be a difference in the approach to 
genotoxic and epigenetic fibres? 5. Should Croatia 
adopt the ILO recommendation that only substances 
proven to be less harmful to human health should be 
introduced as asbestos substitutes?
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Sažetak
DILEMA O AZBESTU: II. ZABRANA
Opisani su zakonski postupci koji su doveli do suprotstavljenih odluka u Europskoj uniji (EU), SAD–u i 
drugim zemljama svijeta u vezi sa zabranom uporabe azbesta. Naglašena je razlika između sadašnje situacije 
u SAD–u u usporedbi s potpunom zabranom uporabe azbesta u zemljama članicama EU do godine 2005. 
Američka agencija za zaštitu okoliša (EPA) donijela je 1989. odluku o zabrani proizvodnje i uporabe svih 
vrsta azbesta. Jedan od apelacijskih sudova SAD–a poništio je 1991. tu odluku s obzirom na to što EPA 
nije analizirala druge mogućnosti da postigne prihvatljivu razinu rizika, a posebno što nije ocijenila rizike 
koji bi nastali uvođenjem predloženih zamjenskih materijala od kojih su neki karcinogeni. To se posebno 
odnosilo na predloženu zabranu azbestnocementnih cijevi za opskrbu vodom i na materijale za automobilske 
kočnice i spojke. Autor se posebno osvrće na odluku EU o potpunoj zabrani proizvodnje i uporabe azbesta 
u zemljama–članicama EU. Upozorava na neobične razlike između dviju ocjena Znanstvenog komiteta EU 
za toksičnost, ekotoksičnost i okoliš (SCTEE) iz početka i kraja 1998. godine o sadašnjoj situaciji u vezi 
s rizikom od azbesta, na temelju kojih je donesena odluka o zabrani. Autor upozorava na kontradiktorne 
navode i interpretacije između prve i druge evaluacije i na slabosti “Znanstvene opravdanosti nove direktive 
EU”.
U radu je kritički analiziran prijedlog Kolegija Ramazzini da se uvede potpuna zabrana uporabe azbesta koja 
bi vrijedila za sve zemlje svijeta. Iako autor prihvaća opravdanost takve inicijative, kritizira je u sadašnjoj fazi, 
dok još nema dovoljno podataka o toksičnosti materijala koji se predlažu kao zamjene za azbest.
KLJUČNE RIJEČI:  EPA–ina zabrana, EU–ova zabrana, krizotil, prijedlog međunarodne zabrane
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